This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Proofpoint (PFPT) Q3 Earnings Surpass Estimates, Surge Y/Y
by Zacks Equity Research
Proofpoint (PFPT) third-quarter results benefit from solid growth in Advanced Threat solutions.
Proofpoint (PFPT) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Proofpoint's (PFPT) Q3 results are likely to benefit from healthy cyber security market, partnerships and acquisitions. However, strong competition and increasing expenses remain concerns.
Proofpoint (PFPT) Q3 Earnings Preview: What to Watch Ahead of the Release
by Zacks Equity Research
Proofpoint (PFPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Proofpoint (PFPT) Enters Oversold Territory
by Zacks Equity Research
Proofpoint, Inc. (PFPT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
6 Cybersecurity Stocks in Focus as Hacking Threatens Elections
by Chandrima Sanyal
Growing data breach concerns ahead of the U.S mid-term elections in November is boosting the prospects of cyber-security firms.
Looking for a Growth Stock? Why It is Time to Focus on Proofpoint (PFPT)
by Zacks Equity Research
Proofpoint (PFPT) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.
Imperva (IMPV) Expands Portfolio With Acquisition of Prevoty
by Zacks Equity Research
Imperva (IMPV) aims to make strategic acquisitions to broaden its technology and offerings, allowing organizations to protect applications and data on premise, in both cloud and hybrid environment.
Solid Q2 Earnings Fail to Lift Cyber Security ETFs
by Sweta Killa
Though the cyber security industry appears well poised on higher IT spending budgets and increased cybercrimes, strong corporate earnings failed to impress the stocks and ETFs.
Proofpoint Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Proofpoint has been struggling lately, but the selling pressure may be coming to an end soon.
CyberArk's (CYBR) Q2 Earnings: Is a Beat in the Offing?
by Zacks Equity Research
CyberArk's (CYBR) Q2 results are likely to benefit from increasing customer base and new enhancements in its privileged access management solutions.